"
Team:Calgary/Project
From 2014.igem.org
| Line 1: | Line 1: | ||
{{Team:Calgary/Main}} | {{Team:Calgary/Main}} | ||
<html> | <html> | ||
| + | |||
| + | |||
| + | <img src="https://static.igem.org/mediawiki/2014/6/64/Projectmap.png" "width=100" class="Center"> | ||
<p><section class="Content Text Color-Normal"> | <p><section class="Content Text Color-Normal"> | ||
| Line 8: | Line 11: | ||
<p>Infectious diseases including dengue fever, typhoid fever, and meningitis are symptomatically similar to malaria, and thus are often misdiagnosed in resource-poor developing countries lacking suitable medical diagnostic facilities. Failure to properly identify such diseases is concerning because it prevents medical professionals from administering appropriate treatments in a timely manner, resulting in economic costs and human suffering <a href="https://2014.igem.org/Team:Calgary/Sandbox/Notebook/References"#Journals>(Mabey, Peeling, Ustianowski, & Perkins, 2004)</a>. To address this issue, the iGEM Calgary 2014 team is developing a novel, genome-based, rapid point-of-care synthetic biological device to simultaneously diagnose multiple infectious diseases. We are engineering Bacillus subtilis to generate a chromophoric reporter protein in response to pathogenic genetic markers indicative of these diseases. These synthetic organisms will lie dormant as robust bacterial spores in a microfluidic device, enabling users to input blood samples and differentiate diseases based on colour of the output reporter proteins. Additionally, our system is a platform technology which can be adapted to detect a myriad of infectious agents by modifying the disease markers to which the system is targeted.</p> | <p>Infectious diseases including dengue fever, typhoid fever, and meningitis are symptomatically similar to malaria, and thus are often misdiagnosed in resource-poor developing countries lacking suitable medical diagnostic facilities. Failure to properly identify such diseases is concerning because it prevents medical professionals from administering appropriate treatments in a timely manner, resulting in economic costs and human suffering <a href="https://2014.igem.org/Team:Calgary/Sandbox/Notebook/References"#Journals>(Mabey, Peeling, Ustianowski, & Perkins, 2004)</a>. To address this issue, the iGEM Calgary 2014 team is developing a novel, genome-based, rapid point-of-care synthetic biological device to simultaneously diagnose multiple infectious diseases. We are engineering Bacillus subtilis to generate a chromophoric reporter protein in response to pathogenic genetic markers indicative of these diseases. These synthetic organisms will lie dormant as robust bacterial spores in a microfluidic device, enabling users to input blood samples and differentiate diseases based on colour of the output reporter proteins. Additionally, our system is a platform technology which can be adapted to detect a myriad of infectious agents by modifying the disease markers to which the system is targeted.</p> | ||
| - | |||
</section> | </section> | ||
</html> | </html> | ||
Revision as of 21:54, 17 October 2014
Our Project
Infectious diseases including dengue fever, typhoid fever, and meningitis are symptomatically similar to malaria, and thus are often misdiagnosed in resource-poor developing countries lacking suitable medical diagnostic facilities. Failure to properly identify such diseases is concerning because it prevents medical professionals from administering appropriate treatments in a timely manner, resulting in economic costs and human suffering (Mabey, Peeling, Ustianowski, & Perkins, 2004). To address this issue, the iGEM Calgary 2014 team is developing a novel, genome-based, rapid point-of-care synthetic biological device to simultaneously diagnose multiple infectious diseases. We are engineering Bacillus subtilis to generate a chromophoric reporter protein in response to pathogenic genetic markers indicative of these diseases. These synthetic organisms will lie dormant as robust bacterial spores in a microfluidic device, enabling users to input blood samples and differentiate diseases based on colour of the output reporter proteins. Additionally, our system is a platform technology which can be adapted to detect a myriad of infectious agents by modifying the disease markers to which the system is targeted.
